Dicerna Pharmaceuticals, Inc. (DRNA) and Novo Nordisk (NVO) have signed an agreement under which Novo Nordisk will acquire Dicerna for $3.
Are we at the start of a boom or a bust? That’s the question on investors’ minds these days, as the world gets …
Alnylam Pharmaceuticals (ALNY) has announced positive Phase 3 results from the ILLUMINATE-A study of lumasiran for the treatment of primary hyperoxaluria type 1 …
Dicerna Pharmaceuticals (NASDAQ:DRNA) shares are shooting up over 30% faster than Jack’s magic bean sparking right into a giant beanstalk. Why the excitement?
